Sandu Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	-	26.53	12.06	22.76	9.39	45.28
Short-Term Investments	-	-	-	0.2	32.33	71.28
Cash & Short-Term Investments	37.21	26.53	12.06	22.96	41.71	116.56
Cash Growth	11.58%	119.93%	-47.45%	-44.96%	-64.21%	656.09%
Accounts Receivable	-	47.57	48.68	47.92	39.91	53.48
Other Receivables	-	0.32	0.62	3.17	4.28	1.24
Receivables	-	49.12	50.32	52.13	45.09	54.92
Inventory	-	141.49	122.51	143.26	112.72	111.38
Prepaid Expenses	-	1.86	1.15	0.76	0.87	1.81
Other Current Assets	-	43.99	37	36.35	36.08	20.76
Total Current Assets	-	262.99	223.04	255.45	236.47	305.43
Property, Plant & Equipment	-	181.22	178.43	169.86	164.5	161.06
Long-Term Investments	-	112.74	122.33	115.61	91.39	2.46
Other Intangible Assets	-	0.24	0.35	0.51	0.35	0.68
Other Long-Term Assets	-	-	0	0.24	0.14	0
Total Assets	-	557.19	524.15	541.66	492.85	469.63
Accounts Payable	-	44.87	41.95	83.98	68.18	66.7
Accrued Expenses	-	30.36	32.98	29.07	25.65	40.88
Short-Term Debt	-	-	-	-	-	0.19
Current Portion of Leases	-	0.58	0.03	-	-	-
Current Income Taxes Payable	-	25	19.12	13.25	15.28	8.32
Current Unearned Revenue	-	6.69	5.15	7.3	6.06	5.34
Other Current Liabilities	-	13.36	7.19	5.24	3.57	3.76
Total Current Liabilities	-	120.86	106.41	138.83	118.74	125.19
Long-Term Leases	-	4.19	0.6	-	-	-
Long-Term Deferred Tax Liabilities	-	11.97	11.21	10.42	9.37	9.53
Other Long-Term Liabilities	-	-	-	-	-	-0
Total Liabilities	-	137.02	118.22	149.25	128.1	134.72
Common Stock	-	96.61	96.61	96.61	88.11	79.21
Additional Paid-In Capital	-	27.58	27.58	27.58	18.49	8.98
Retained Earnings	-	190.27	180.88	171.95	161.8	144.76
Comprehensive Income & Other	-	105.71	100.86	96.27	96.35	101.96
Shareholders' Equity	422.34	420.17	405.93	392.41	364.75	334.91
Total Liabilities & Equity	-	557.19	524.15	541.66	492.85	469.63
Total Debt	4.48	4.78	0.63	-	-	0.19
Net Cash (Debt)	32.72	21.76	11.43	22.96	41.71	116.37
Net Cash Growth	16.14%	90.33%	-50.21%	-44.96%	-64.16%	3823.48%
Net Cash Per Share	3.37	2.25	1.18	2.43	4.91	16.43
Filing Date Shares Outstanding	9.65	9.66	9.66	9.66	8.81	7.92
Total Common Shares Outstanding	9.65	9.66	9.66	9.66	8.81	7.92
Working Capital	-	142.13	116.63	116.62	117.74	180.24
Book Value Per Share	43.50	43.49	42.02	40.62	41.40	42.28
Tangible Book Value	422.14	419.93	405.58	391.91	364.4	334.23
Tangible Book Value Per Share	43.48	43.47	41.98	40.57	41.36	42.20
Buildings	-	86.16	86.16	85.84	81.31	81.31
Machinery	-	102.66	97.61	81.87	75.42	71.83
Construction In Progress	-	-	-	4.2	4.82	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.